Chengdu Kanghua Biological Products Co., Ltd.

40
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003Y57
CNY
79.70
-2.55 (-3.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Chengdu Kanghua Biological Products Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
467.00
573.00
683.00
915.00
483.00
223.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7.00
-43.00
-444.00
-468.00
-61.00
-37.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
573.00
574.00
195.00
134.00
371.00
182.00
Cash Flow from Investing Activities
-342.00
-163.00
-412.00
-206.00
-443.00
-23.00
Cash Flow from Financing Activities
-471.00
-7.00
-73.00
-147.00
975.00
-9.00
Net Cash Inflow / Outflow
-239.00
403.00
-290.00
-218.00
903.00
149.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CNY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Chengdu Kanghua Biological Products Co., Ltd.
Figures in Million
Markets Mojo
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -0.18% vs 193.77% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
573.28
574.33
-0.18%